7 Amazing Everyday Examples Of Nanotechnology In Action – Forbes

Nanotechnology essentially means controlling matter on a tiny scale, at the atomic and molecular level. This sounds truly sci-fi, but can, in fact, be put to some very ordinary uses in surprisingly everyday products. In this article, well explore common products that make use of nanotechnology but first, lets get a quick overview of the amazing world of nanotechnology...

7 Amazing Everyday Examples Of Nanotechnology In Action

What is nanotechnology?

Nanotechnology is about looking at the world on such a tiny scale that we can not only see the atoms that make up everything around us (including ourselves), but we can manipulate and move those atoms around to create new things. Think of nanotechnology, then, as being a bit like construction only on a tiny scale.

And I do mean tiny. The nanoscale is 1,000 times smaller than the microscopic level and a billion times smaller than the typical world of meters that were used to measuring things in. (Nano literally means one-billionth.) If you took a human hair, for instance, it would measure approximately 100,000 nanometers wide. Thats the sort of scale were dealing with at a nano level.

Thats all very cool, I hear you say, but how does understanding this nanoscopic world impact (if youll excuse the pun) the world at large? For one thing, when we zoom in and look at materials on an atomic level, we sometimes find they behave quite differently and have completely different properties at the atomic level. As a simple example, silk feels incredibly soft and delicate to the touch, but if you look at it at a nano-level, youll see its made up of molecules aligned in cross-links, and this is what makes silk so strong. We can then use knowledge like this to manipulate other materials at a nano level, to create super-strong, state-of-the-art materials like Kevlar.

This is where the technology bit of nanotechnology comes in using our knowledge of materials at a nano-level to create exciting new solutions and products.

Everyday products that use nanotechnology

Nanotechnology may seem like something out of the future, but in fact, many everyday products are already made using nanotechnology. Take these seven common products, for instance:

1. Sunscreen

Nanoparticles have been added to sunscreens for years to make them more effective. Two particular types of nanoparticles commonly added to sunscreen are titanium dioxide and zinc oxide. These tiny particles are not only highly effective at blocking UV radiation, they also feel lighter on the skin, which is why modern sunscreens are nowhere near as thick and gloopy as the sunscreens we were slathered in as kids.

2. Clothing

When used in textiles, nanoparticles of silica can help to create fabrics that repel water and other liquids. Silica can be added to fabrics either by being incorporated into the fabrics weave or sprayed onto the surface of the fabric to create a waterproof or stainproof coating. So if youve ever noticed how liquid forms little beads on waterproof clothing beads that simply roll off the fabric rather than being absorbed thats thanks to nanotechnology.

3. Furniture

In the same way that clothing can be made waterproof and stainproof through nanotechnology, so too can upholstered furniture. Even better, nanotechnology is also helping to make furniture less flammable; by coating the foam used in upholstered furniture with carbon nanofibers, manufacturers can reduce flammability by up to 35 percent.

4. Adhesives

Nanotechnology can also be used to optimize adhesives. Interestingly, most glues lose their stickiness at high temperatures, but a powerful nano-glue not only withstands high temperatures it gets stronger as the surrounding temperature increases.

5. Coatings for car paintwork

We all know bird droppings can wreak havoc on car paintwork. To combat this, a company called Nanorepel has produced a high-performance nanocoating that can be used to protect your cars paintwork from bird poop. The company also makes coatings to protect car upholstery from stains and spillages.

6. Tennis balls

Nanotechnology has found a range of applications in the world of sports equipment, with a couple of great examples coming from one of my favorite sports: tennis. Nanotechnology helps tennis balls keep their bounce for longer, and make tennis racquets stronger.

7. Computers

Without nanotechnology, we wouldn't have many of the electronics we use in everyday life. Intel is undoubtedly a leader in tiny computer processors, and the latest generation of Intels Core processor technology is a 10-nanometer chip. When you think a nanometer is one-billionth of a meter, thats incredibly impressive!

Nanotechnology is just one of 25 technology trends that I believe will transform our society. Read more about these key trends including plenty of real-world examples in my new book, Tech Trends in Practice: The 25 Technologies That Are Driving The 4th Industrial Revolution.

Link:
7 Amazing Everyday Examples Of Nanotechnology In Action - Forbes

Thessaloniki to host leading nanotechnology conference starting 4 July – TheMayor.EU

Thessaloniki is set to become the centre of high tech entrepreneurship and science for a week, during the leading conference on nanotechnology and nanoscience Nanotechnology 2020. The conference is set to begin on 4 July and carry on for 7 days until 11 July.

Due to the exceptional circumstances that we all find ourselves in, related to the coronavirus pandemic, the city and the conference alike have had to adapt to a radically different way of doing things. Putting aside the now usual and strictly enforced hygienic and social distancing measures observed by authorities and organisers, Nanotechnology 2020 will also shift its gears namely towards digitizing its delivery of content.

For the first time, the conference will be held both live with all the present guests adhering to strict measures and online in order to reach as many people as possible more specifically those who will not be able to attend due to travel bans and the suspensions of flights.

The conference will gather together the top scientists, engineers, university representatives and tech companies to the table in order to learn from each other and discuss and promote new nanotechnology products as well as the growth of the entire sector itself.

Perhaps the most topical and most interesting of the panels will be those related specifically to COVID-19 and its handling and spread. Many new innovations will be presented on the conference floor which might prove useful to authorities throughout Europe when they are devising new approaches to dealing with the pandemic.

Nanotechnologies are already being employed in Europes cities in order to disinfect surfaces, allowing citizens to be and feel safer when traversing the urban area. Such is the case in Prague, with the local government embracing new technologies in order to protect the life and health of its constituents.

TheMayor.EU stands against fake news and disinformation. If you encounter such texts and materials online, contact us at info@themayor.eu

Read more from the original source:
Thessaloniki to host leading nanotechnology conference starting 4 July - TheMayor.EU

Nanotechnology and Nanomaterials Market Size, Future Trends, Segmentation, Gross Margin, Opportunity Assessment and Potential of the Industry by 2027…

Market Expertz has published a new report on the Global Nanotechnology and Nanomaterials Market. This report gives the Nanotechnology and Nanomaterials Market Profitability Analysis, raw material and supply chain analysis, market entry tactics, recent developments & their impact on the market, prospects of Nanotechnology and Nanomaterials Market, Opportunities, year-on-year growth rate, SWOT analysis, PESTEL analysis, market estimates, size, and forecast for product segments from 2020 to 2027.

A detailed study of the Nanotechnology and Nanomaterials market competitors and participants, alongside their market strategies, to better help the users to formulate plans of their own. The market is seen from the perspective of the potential investors and competitors, and the optimized routes to gain share in the Nanotechnology and Nanomaterials global industry are also mentioned.

This is the only report that is inclusive of the current effect of the coronavirus on the market and its forecasted trend. The coronavirus attack on the world economy has affected all industries, and its impacts are elucidated in-depth in the report for the Nanotechnology and Nanomaterials market.

Get FREE Sample Copy with TOC of the Report to understand the structure of the complete [emailprotected] https://www.marketexpertz.com/sample-enquiry-form/83996

Nanotechnology and Nanomaterials product types, applications, geographies, and end-user industries are the key market segments that are comprised in this study. The report speculates the prospective growth of the different market segments by studying the current market standing, performance, demand, production, sales, and growth prospects existing in the market.

The segmentation included in the report is beneficial for readers to capitalize on the selection of appropriate segments for the Nanotechnology and Nanomaterials sector and can help companies in deciphering the optimum business move to reach their desired business goals.

The report includes accurately drawn facts and figures, along with graphical representations of vital market data. The research report sheds light on the emerging market segments and significant factors influencing the growth of the industry to help investors capitalize on the existing growth opportunities.

!!! Limited Time DISCOUNT Available!!! Get Your Copy at Discounted [emailprotected] https://www.marketexpertz.com/discount-enquiry-form/83996

Geographical regions covered in this report:

Major Points Covered in The Report:

Read the full Research Report along with a table of contents, facts and figures, charts, graphs, etc. @ https://www.marketexpertz.com/industry-overview/2020-nanotechnology-and-nanomaterials-market

To summarize, the global Nanotechnology and Nanomaterials market report studies the contemporary market to forecast the growth prospects, challenges, opportunities, risks, threats, and the trends observed in the market that can either propel or curtail the growth rate of the industry. The market factors impacting the global sector also include provincial trade policies, international trade disputes, entry barriers, and other regulatory restrictions.

About Us:Planning to invest in market intelligence products or offerings on the web? Then marketexpertz has just the thing for you reports from over 500 prominent publishers and updates on our collection daily to empower companies and individuals catch-up with the vital insights on industries operating across different geography, trends, share, size and growth rate. Theres more to what we offer to our customers. With marketexpertz you have the choice to tap into the specialized services without any additional charges.

Contact Us:John WatsonHead of Business Development40 Wall St. 28th floor New York CityNY 10005 United StatesDirect Line: +1-800-819-3052Visit our News Site: http://newssucceed.com

Continue reading here:
Nanotechnology and Nanomaterials Market Size, Future Trends, Segmentation, Gross Margin, Opportunity Assessment and Potential of the Industry by 2027...

Nanotechnology in Dental Implant Market (impact of COVID-19) with Top Players: Zimmer Biomet,Heraeus Kulzer,3M,Nobel Biocare and Others – Cole of Duty

Global Nanotechnology in Dental Implant Market: Trends Estimates High Demand by 2027

The Nanotechnology in Dental Implant Market 2020 report includes the market strategy, market orientation, expert opinion and knowledgeable information. The Nanotechnology in Dental Implant Industry Report is an in-depth study analyzing the current state of the Nanotechnology in Dental Implant Market. It provides a brief overview of the market focusing on definitions, classifications, product specifications, manufacturing processes, cost structures, market segmentation, end-use applications and industry chain analysis. The study on Nanotechnology in Dental Implant Market provides analysis of market covering the industry trends, recent developments in the market and competitive landscape.

It takes into account the CAGR, value, volume, revenue, production, consumption, sales, manufacturing cost, prices, and other key factors related to the global Nanotechnology in Dental Implant market. All findings and data on the global Nanotechnology in Dental Implant market provided in the report are calculated, gathered, and verified using advanced and reliable primary and secondary research sources. The regional analysis offered in the report will help you to identify key opportunities of the global Nanotechnology in Dental Implant market available in different regions and countries.

The final report will add the analysis of the Impact of Covid-19 in this report Nanotechnology in Dental Implant industry.

Some of The Companies Competing in The Nanotechnology in Dental Implant Market are: Zimmer Biomet,Heraeus Kulzer,3M,Nobel Biocare,Sirona,Gendex,Osartis,Ivoclar Vivadent,Danaher Corporation,Straumann Holding,aap Implantate,Biotronik,Orthovita (Stryker),Nucryst.

Get a Sample Copy of the [emailprotected] https://www.reportsandmarkets.com/sample-request/covid-19-impact-on-global-and-japan-nanotechnology-in-dental-implant-market-2020-by-company-type-and-application-forecast-to-2025?utm_source=coleofduty&utm_medium=46

The report scrutinizes different business approaches and frameworks that pave the way for success in businesses. The report used Porters five techniques for analyzing the Nanotechnology in Dental Implant Market; it also offers the examination of the global market. To make the report more potent and easy to understand, it consists of info graphics and diagrams. Furthermore, it has different policies and improvement plans which are presented in summary. It analyzes the technical barriers, other issues, and cost-effectiveness affecting the market.

Global Nanotechnology in Dental Implant Market Research Report 2020 carries in-depth case studies on the various countries which are involved in the Nanotechnology in Dental Implant market. The report is segmented according to usage wherever applicable and the report offers all this information for all major countries and associations. It offers an analysis of the technical barriers, other issues, and cost-effectiveness affecting the market. Important contents analyzed and discussed in the report include market size, operation situation, and current & future development trends of the market, market segments, business development, and consumption tendencies. Moreover, the report includes the list of major companies/competitors and their competition data that helps the user to determine their current position in the market and take corrective measures to maintain or increase their share holds.

What questions does the Nanotechnology in Dental Implant market report answer pertaining to the regional reach of the industry?

The report claims to split the regional scope of the Nanotechnology in Dental Implant market into North America, Europe, Asia-Pacific, South America & Middle East and Africa. Which among these regions has been touted to amass the largest market share over the anticipated duration

How do the sales figures look at present how does the sales scenario look for the future?

Considering the present scenario, how much revenue will each region attain by the end of the forecast period?

How much is the market share that each of these regions has accumulated presently

How much is the growth rate that each topography will depict over the predicted timeline

A short overview of the Nanotechnology in Dental Implant market scope:

Global market remuneration

Overall projected growth rate

Industry trends

Competitive scope

Product range

Application landscape

Supplier analysis

Marketing channel trends Now and later

Sales channel evaluation

Market Competition Trend

Market Concentration Rate

Reasons to Read this Report

This report provides pin-point analysis for changing competitive dynamics

It provides a forward looking perspective on different factors driving or restraining market growth

It provides a six-year forecast assessed on the basis of how the market is predicted to grow

It helps in understanding the key product segments and their future

It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors

It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments

TABLE OF CONTENT:

Chapter 1:Nanotechnology in Dental Implant Market Overview

Chapter 2: Global Economic Impact on Industry

Chapter 3:Nanotechnology in Dental Implant Market Competition by Manufacturers

Chapter 4: Global Production, Revenue (Value) by Region

Chapter 5: Global Supply (Production), Consumption, Export, Import by Regions

Chapter 6: Global Production, Revenue (Value), Price Trend by Type

Chapter 7: Global Market Analysis by Application

Chapter 8: Manufacturing Cost Analysis

Chapter 9: Industrial Chain, Sourcing Strategy and Downstream Buyers

Chapter 10: Marketing Strategy Analysis, Distributors/Traders

Chapter 11: Nanotechnology in Dental Implant Market Effect Factors Analysis

Chapter 12: GlobalNanotechnology in Dental Implant Market Forecast to 2027

Get Complete Report @ https://www.reportsandmarkets.com/sample-request/covid-19-impact-on-global-and-japan-nanotechnology-in-dental-implant-market-2020-by-company-type-and-application-forecast-to-2025?utm_source=coleofduty&utm_medium=46

About Us:

Reports And Markets is part of the Algoro Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe. Are you mastering your market? Do you know what the market potential is for your product, who the market players are and what the growth forecast is? We offer standard global, regional or country specific market research studies for almost every market you can imagine.

Contact Us:

Sanjay Jain

Manager Partner Relations & International Marketing

http://www.reportsandmarkets.com

Ph: +1-352-353-0818 (US)

More:
Nanotechnology in Dental Implant Market (impact of COVID-19) with Top Players: Zimmer Biomet,Heraeus Kulzer,3M,Nobel Biocare and Others - Cole of Duty

Advanced nanotechnology used to improve success of dental implants – Bite magazine

A technological advancement that may prove crucial in the long-term success of dental implants has been developed by University of Queensland researchers.

Dr Karan Gulati, NHMRC Early Career Fellow from theUQ School of Dentistry, said modifying dental implants with nanopores will help protect against one of the leading causes of implant failure.

Poor integration between the implant and the surrounding tissue is one of the leading causes of dental implant failure, Dr Gulati said.

If the sealing between the implant and the surrounding gum tissue fails, it can result in bacteria entering the implant and causing infection.

Our simple solution is the fabrication of nanoporeswhich are tiny nano-scale holes of just 40 to 80 nanometres in diameterto cover the entire surface of the implant.

Dr Gulati and colleaguestheir proof of concept study is published inMaterials Science and Engineering: Cfound that soft-tissue cells attach well onto the nanopores, resulting in better soft-tissue seal formation.

We can also control the cell functions to achieve a more enhanced soft-tissue integration, he said.

Dr Gulati is hopeful that human trials will begin next year.

We have optimised the protocols and the therapies, now we are ready to turn the research into reality, he said.

This article was sourced from the UQ School of Dentistry news website.

Read this article:
Advanced nanotechnology used to improve success of dental implants - Bite magazine

Global Nanotechnology in Drug Delivery Market SHARE, SIZE 2020| EMERGING RAPIDLY WITH LATEST TRENDS, GROWTH, REVENUE, DEMAND AND FORECAST TO 2026 -…

Global Nanotechnology in Drug Delivery Market is an extensive compilation of in-depth analysis, factual assessments, value chain structure, industrial environment, regional analysis, applications, market size, share, and forecast. The report explains historic and current market status to provide comprehension for forthcoming occurrences in the market. The report provides an overall analysis of the market based on types, applications, regions, and the forecast period from 2020 to 2025. It also offers investment opportunities and probable threats in the market based on an intelligent analysis. The research will help you to depict the entire global Nanotechnology in Drug Delivery market through authentic and reliable estimation.

Our report highlights the major issues and hazards that companies might come across due to the unprecedented outbreak of COVID-19.

DOWNLOAD FREE SAMPLE: https://www.magnifierresearch.com/report-detail/28943/request-sample

Competitive Landscape:

The report examines the global Nanotechnology in Drug Delivery market competition by focusing on leading industry players with information such as company profiles, components, and services offered, financial information of the past years, key developments in the previous years. The study presents the strengths and weaknesses of these companies and provides information about various strategies used by these players. The key strategies used by the leading players such as new products, innovation, expanding business through mergers, acquisitions, and partnerships are highlighted.

The most significant players coated in global Nanotechnology in Drug Delivery market report: Access Pharmaceuticals, Alkermes, Aquanova, Camurus, Capsulution Pharma, Celgene,

Scope of The Market Report:

The report offers a forward-looking perspective on different factors driving or limiting the market growth. An exceptionally workable estimation of the present industry scenario has been delivered in the study, and the global Nanotechnology in Drug Delivery market size with regards to the revenue and volume have also been mentioned. In short, the report provides a detailed analysis of the global market size, regional and country-level market size, segment growth, market share, competitive landscape, sales analysis, the impact of domestic and global market players, value chain optimization, trade regulations, and recent developments in different regions.

The report offers an in-depth assessment of the growth and other aspects of the market in key countries including the

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Global Nanotechnology in Drug Delivery market by Type:

Global Nanotechnology in Drug Delivery market by application: Cancer, Tumor, Other

READ FULL REPORT: https://www.magnifierresearch.com/report/global-nanotechnology-in-drug-delivery-market-size-status-28943.html

The Listing Supplies Hints On The Upcoming Pointers:

Business Diversification: Market information about new services, untapped geographies, the latest advances, and also investments.

Assessment: In-depth investigation of plans, services, and manufacturing capabilities of these top players.

Business Intelligence: Comprehensive information on Nanotechnology in Drug Delivery made accessible the very active players in the global sector.

Product Development/Innovation: Comprehensive information about technology, R&D pursuits, together with brand new product launches out of the global Nanotechnology in Drug Delivery market.

Market Development: Comprehensive information regarding flourishing emerging markets in which the report assesses the market to get worldwide records

Customization of the Report:This report can be customized to meet the clients requirements. Please connect with our sales team ([emailprotected]), who will ensure that you get a report that suits your needs. You can also get in touch with our executives on +1-201-465-4211 to share your research requirements.

About Us

Magnifier Research is a leading market intelligence company that sells reports of top publishers in the technology industry. Our extensive research reports cover detailed market assessments that include major technological improvements in the industry. Magnifier Research also specializes in analyzing hi-tech systems and current processing systems in its expertise. We have a team of experts that compile precise research reports and actively advise top companies to improve their existing processes. Our experts have extensive experience in the topics that they cover. Magnifier Research provides you the full spectrum of services related to market research, and corroborate with the clients to increase the revenue stream, and address process gaps.

Contact UsMark StoneHead of Business DevelopmentPhone:+1-201-465-4211Email:[emailprotected]Web:www.magnifierresearch.com

The rest is here:
Global Nanotechnology in Drug Delivery Market SHARE, SIZE 2020| EMERGING RAPIDLY WITH LATEST TRENDS, GROWTH, REVENUE, DEMAND AND FORECAST TO 2026 -...

Earlier diagnosis and better treatment for type 1 diabetes – Advanced Science News

Nanotechnology is poised to revolutionize the diagnosis and treatment of patients with type 1 diabetes.

According to the WHO, in 2016, an estimated 1.6 million deaths were directly caused by diabetes. It is a chronic disease that occurs when the body is unable to produce or process a hormone called insulin, which helps regulate blood sugar levels.

Of the three major types, type 1 diabetes has proven to be the most problematic in terms of providing patients with a timely diagnosis, as patients may be asymptomatic for long periods of time with a sudden onset of symptoms well into the diseases progression.

Currently, type 1 diabetes can be diagnosed at any age, but it is mostly found in children and adolescents. Once diagnosed, patients also have a high risk of diabetes-related complications, as well as other autoimmune diseases, such as hashimotos thyroiditis or celiac disease. Therefore, early diagnosis and treatment could prevent the progression of type 1 diabetes.

At present, the diagnosis of type 1 diabetes depends on the detection of blood glucose levels and islet autoantibodies, which are markers that appear when insulin producing islet cells clusters of hormone producing cells in the pancreas are damaged. But the function of the patients cells have likely already been severely damaged by the time they receive a diagnosis.

As more and more people suffer from type 1 diabetes of the 422 million people worldwide diagnosed with diabetes in 2016, roughly 5% were categorized as type 1 the importance of early diagnosis and the urgency of effective treatments becomes ever more important. However, recent medical methods for the early diagnosis of type 1 diabetes are still limited. So, its important to develop new methods for early diagnosis and treatment.

Nanomedicine is an emerging field and provides a promising and more effective alternative to diagnose type 1 diabetes, and stands to revolutionize treatment for patients. Experts in this field, Dr. Yuanzeng Min from the School of Chemistry and Material Science at the University of Science and Technology of China (USTC) and Dr. Jianping Weng, a clinician from the First Affiliated Hospital of USTC discuss the findings in a recent reviewpublished in WIREs Nanomedicine and Nanobiotechnology.

Magnetic resonance imaging (MRI) has in itself revolutionized imaging in medicine. It takes advantage of powerful magnets to make a detailed internal picture of the body and helps doctors diagnose otherwise unseen disease or injury. To improve this technique and make it more suitable to diagnosing patients with type 1 diabetes, scientists have explored using common biomarkers of the disease, such as inflammation, and enhancing physicians ability to detect them in MRI analysis using helper materials. In this sense, nanomaterials have been shown great promise in facilitating the accumulation of imaging substrates at the targeted site, thus improving the quality of MRI imaging and the accuracy of diagnosis.

An excellent example of this is the clinical use of the nanoparticle ferumoxtran-10 or ferumoxytol. In clinical studies, there was an observed increase in pancreatic accumulation of this imaging nanoparticle in inflamed islets of type 1 diabetes patients in comparison to a healthy control group. This method is non-invasive, and the imaging materials are readily metabolized by the body without harmful side effects. This technique has been ground-breaking in visualizing insulitis, an inflammatory lesion and an early stage marker of type 1 diabetes.

Type 1 diabetes is classified as an autoimmune disease in which insulin-producing cells are destroyed by the bodys own immune system, and is affected by a number of factors, such as genetics, environment and metabolism, among others. The downregulation of the overactive immune cells that kill the insulin-producing cells has been gathering more and more attention in the medical and research community.

Studies have shown that nanoparticles have the beneficial characteristics of high drug loading and are capable of being targeted to a specific location in the body, minimizing harmful side effects usually observed in these types of therapies. Scientists have used loaded nanoparticles to carry antigenic peptides or pMHC (peptide major histocompatibility complex) to suppress the bodys immune response so that the immune cells no longer attack cells. Research has also explored encapsulating cytokines or other synthesized molecules to modulate the immune system into the nanoparticles, which could be locally administered along with modulating immune cells, such as T cells or APCs (antigen presenting cells).

Significant progress in the development of sophisticated nanotechnologies has also been seen in the past 10 years for immunotherapy and islet transplantation in type 1 diabetes. Nanotechnology has played a significant role in islet transplantation by encapsulating healthy cells with biomaterials as most of the insulin-producing cells are destroyed by the patients own immune system. The biomaterials also protect the transplanted cells from immune exclusion. In addition to avoiding a deleterious host response, encapsulated islets must receive an adequate nutrient supply and positive extracellular cues in order to survive and functionin vivo.Thus, while using nanotechnology to encapsulate cells, it alsorequires as little interference as possible with the generation of new blood vessels in the encapsulation. This is usually achieved by improving the mechanical rigidity, charge distribution, morphology, and other related parameters of the nanomaterials.

While great strides have been made, limitations in the application of nanotechnology in diagnosis and treatment of type 1 diabetes remain. For example, some nanoparticles are not specifically target islets, their production process can be complicated, and the cost is high. However, their application in this area of medicine has only just begun, and we are beginning to see the benefits of this research in clinical trials.

With research in type 1 diabetes and the development of nanotechnology, these problems will hopefully one day be solved. We believe that in the next 10-20 years there will be high chance of this type of therapy used regularly in the clinical diagnosis and treatment oftype 1 diabetes patients.

Written by: Yuanzeng Min and Jianping Weng

Reference: Wen Pan, et al. Nanotechnologys application in Type 1 diabetes. WIREs Nanomedicine and Nanobiotechnology (2020). DOI: 10.1002/wnan.1645

Visit link:
Earlier diagnosis and better treatment for type 1 diabetes - Advanced Science News

Improve alignment of research policy and societal values – Science Magazine

Historically, scientific and engineering expertise has been key in shaping research and innovation (R&I) policies, with benefits presumed to accrue to society more broadly over time (1). But there is persistent and growing concern about whether and how ethical and societal values are integrated into R&I policies and governance, as we confront public disbelief in science and political suspicion toward evidence-based policy-making (2). Erosion of such a social contract with science limits the ability of democratic societies to deal with challenges presented by new, disruptive technologies, such as synthetic biology, nanotechnology, genetic engineering, automation and robotics, and artificial intelligence. Many policy efforts have emerged in response to such concerns, one prominent example being Europe's Eighth Framework Programme, Horizon 2020 (H2020), whose focus on Responsible Research and Innovation (RRI) provides a case study for the translation of such normative perspectives into concrete policy action and implementation. Our analysis of this H2020 RRI approach suggests a lack of consistent integration of elements such as ethics, open access, open innovation, and public engagement. On the basis of our evaluation, we suggest possible pathways for strengthening efforts to deliver R&I policies that deepen mutually beneficial science and society relationships.

Read more from the original source:
Improve alignment of research policy and societal values - Science Magazine

Investing in Nanotechnology Stocks and Companies – Nanalyze

Top Gun was the highest grossing film of the year, Rock Me Amadeus by Falco was the #1 single of the year, Cosby Show was the top television show, and the Chicago Bears won the Superbowl. It was 1986, the same year a much lesser known event took place. An American engineer named Eric Drexler published a book titled Engines of Creation: The Coming Era of Nanotechnology. It was because of that book that we began researching how to invest in nanotechnology stocks way back in 2003.

(Disclaimer: A lot of articles well be linking to in this piece are very old. Back then, many of us were writing and producing research while attending full-time MBA programs. Consequently, some of it is riddled with typos, poor grammar, and the occasional cuss word. Nowadays, we employ professional writers to ensure that our research team writes prose as well as they can research. That was the idea anyways.)

The textbook description of nanotechnology is simply the study of anything that measures less than 100 nanometers. When you start to examine objects at a molecular scale, everything starts to change as quantum effects create unique properties in materials. For example, silver nanoparticles can act as antimicrobial agents that are effective in killing multi-drug resistant bacteria.

When you consider that the majority of biological processes occur at the nanoscale, its easy to see how broadly the term can be used:

Nanotechnology as defined by size is naturally very broad, including fields of science as diverse as surface science, organic chemistry, molecular biology, semiconductor physics, energy storage, microfabrication, molecular engineering, etc.

The term molecular engineering falls under nanotechnology, and under that you have things like synthetic biology and gene editing, the later of which is perhaps the most exciting emerging technology weve ever covered. Before we tell you why that is, were going to talk a bit about the evolution of nanotechnology over time.

Scientists from around the world successfully finished sequencing about 99% of the human genome, and Murica tried to piss off The Frogs by renaming french fries to freedom fries. It was 2003, the same year that George Dubyah Bush signed the Nanotechnology Research and Development Act. We had just started Nanalyze as a forum to discuss investing in nanotechnology, and within months we were being read by analysts from every investment bank out there. Exciting startups like Nanosys and Molecular Imprints were expected to transform the electronics industry. There seemed to be many stocks for investing in nano Flamel and Skyepharma were doing nano drug delivery, NVE Corporation was bringing us carbon nanotube RAM, and Altair Technologies was supposed to provide us all with the nanomaterials we needed to change the world. FEI Corporation and Veeco Instruments were supposed to be pick-and-shovel investments for microscopes that let us view things at the nano level. My, how things have changed.

Through the years that followed, we saw a proliferation of over-the-counter stocks trying to take advantage of naive retail investors, some of whom had never made an investment before in their lives. What followed was a series of battles with some of the more popular OTC companies. We would publish content debunking whatever bullisht they were selling, and they would fire back at us with cease-and-desists and sometimes even physical threats. We were invited to participate in a real boiler room in hopes we could be bribed. We wrote about that too.

Its difficult to describe just how badly investors were duped, even accredited investors who were sophisticated enough to see through scams. Countless penny stocks started to go under as the pump-and-dumps finished their last leg. Some tried to paint a picture of a technology that didnt live up to its promises, or a management team that couldnt quite get investors to believe in their grand visions. For the investors who lost all their money in nanotechnology penny stocks, did the real reason even matter?

In reading about companies that have failed, we can better understand how to find those that will succeed. Here are just a few examples of nanotechnology companies that never quite followed through on their promises:

When we moved to a publishing format in 2013, we again found the need to continue warning investors about the dangers of investing in OTC stocks or penny stocks. (Just dont do it, no matter what promises youre being told.) We also found that the same companies that were promising us nanomaterial breakthroughs in 2004 were still making those same promises nine years later. Anyone remember Startpharma and Vivagel?

Meaningful revenues are commercial validation for your technology, not grants. With the exception of some biotech firms, we just cant take companies seriously that continue to promise revenues and never deliver on them. Over the years, many promising nanomaterials have been on the cusp of commercialization but never seem to really quite get there. Remember carbon nanotubes?

Carbon nanotubes are tiny cylindrical structures made from carbon with superior properties found in no other material like strength and conductivity. They were expected to bring us space elevators and carbon nanotube random access memory (RAM) what Nanteros labeled NRAM. What we got were some specialty products and carbon nanotube materials but nothing to write home about. The worlds biggest nanotechnology company at least is was back in 2014 is a Russian firm that sells their TUBALL line of carbon nanotube additives.

People quickly forgot about how the carbon nanotube was expected to change the world when it was replaced by another promising nanostructure called graphene.

Graphene is a sheet of atoms that you can pick up. Thats how strong it is. Take a sheet of cellophane made out of graphene and spread it out. Under the sheet, stick a pencil pointing upward (pencils BTW are made with graphite, not graphene). You can place the weight of an elaphant on that sheet and the pencil wont poke through it.

In addition to strength, graphene has numerous magical properties that made investors line up with open checkbooks. The story of graphene disappointing as it is requires a lot more than just a few paragraphs. For the sake of brevity, well say that there are plenty of graphene stocks out there but few that are showing any meaningful revenues from successfully commercializing graphene. As for private companies, there are also some success stories like Skeleton Technologies which uses a proprietary material they refer to as curved graphene which is the basis for the competitive advantage their ultracapacitor cells possess primarily on price and power density.

In addition to carbon nanotubes and graphene, a number of other carbon-based nanomaterials cropped up like fullerenes which also had superior properties that were supposed to generate exponential value for investors. One such class of nanomaterials were quantum dots.

According to MiliporeSigma (used to be Sigma-Aldrich before being acquired by Merck) quantum dots are tiny particles or nanocrystals of a semiconducting material with diameters in the range of 2-10 nanometers. Applications that were initially targeted included displays like television. A startup called QD-Vision was selling quantum dots that where used in Sony televisions (they were later acquired by Samsung). Another quantum dot startup called QD Light was targeting the LED market. Israeli startup StoreDot is developing quantum dots which are organic and metal free for use in batteries and displays (theyve since sold their battery tech to BP). Researchers keep talking about all the great things they can do with quantum dots but commercialized applications seem far and few between.

There is no shortage of interesting nanomaterials out there including nanowires, nanofibers, nanocellulose, metal mesh, nano inks, nano films, nanocomposites, and aerogels, one of the worlds most exotic nanomaterials. Most of the opportunity appears to suround nanotechnology startups that are still taking in funding from venture capital firms. Landa Group is reinventing digital printing with nano ink. Nanotronics is rethinking what a microscope should look like. Vaxxas is working on needle-free vaccinations.

At least seven startups are applying nanotechnology to clothing. Companies like Modumetal and Nanosteel are working on nano-enabled metals. A handful of startups are trying to commercialize metamaterials. Europlasma, HZO, andP2iare all developing methods to waterproof electronics using nanotechnology. NanoTouch is working on self-cleaning surfaces.

There are also applications for nano that can help heal the planet. NanoH2O is desalinating sea water while Diamond Foundryis manufacturing synthetic diamonds. Startup 24M Technologies uses nanoparticles to create a black goo-powered battery for grid energy storage. Nexeon is using silicon nanowires to create a better anode, and so is Amprius. There are a lot of exciting things happening in the world of nanotechnology, so lets see how retail investors might be able to get some exposure to nano stocks.

Youll be disappointed to hear that there are no nanotechnology ETFs right now, but that hasnt always been the case. When nanotechnology was popular among investors, there was actually an index of nano companies called the Merrill Lynch Nanotech Index. That index was discontinued, probably because it under-performed and interest in nanotechnology dried up. Below is a list of stocks that used to be in that index.

There was also the Lux Nanotech Index which didnt perform very well and was also discontinued, though a handful of constituents did manage to beat the broader market, nanotechnology or not.

Weve talked about how prolific nano penny stocks were, but we havent talked about more legitimate companies with revenues that havent been able to quite take off yet. Weve been watching Nanophase for over half a decade now and the $17 million company still hasnt been able to do much. Who wants to park their money in some company thats supposed to be seeing disruptive growth but instead has falling revenues and rising costs?

Then theres Nanosphere. We first wrote about their gold nanoparticle technology back in 2013 noting that the companys shares had fallen over 90% since their 2007 IPO giving them a market cap of $110 million. They were apparently still over-priced. Three years later, Nanosphere was acquired by Luminex for $83 million. If youd been in it for the long haul, you would have lost a lot of money.

Then you have companies not in the Merrill Lynch list like quantum dot developer Nanoco which finally has the numbers going in the right direction after punishing investors for years with the promise of quantum dots and quantum dot televisions, and little to show for it.

Another popular nanotechnology company among investors was Altair Nanotechnologies which nano pundit Josh Wolfe characterized as a nano pretender stating that Altair had changed names more often than Oprahs clothes. When we last checked, the companys flagship product was the Altairnano Energy Storage Systemwhich was expected to target the renewable energy industry. After their CEO resigned and the company appeared to be having financial difficulties, the company continued to air their dirty laundry until finally they voluntarily delisted their stock.

Another popular stock in the nano hype days was Harris & Harris Group which was a publicly traded venture capital firm which dabbled in nano. Theyve since changed their name to 180 Degree Capital and pivoted into other investment areas as their share price continues to languish.

Going forward, we can break down the nanotechnology opportunity into three major themes: nanomaterials including graphene, nano drug delivery, and synthetic biology including gene editing.

What investors need to remember is that companies which use nanomaterials for a competitive advantage wont neccesarily be telling the world about it. Many large-cap companies use nanotechnology in their products. One of our favorite dividend growth investing stocks, 3M, has been using nanotechnology in their products for decades. In the late 1990s, 3M revolutionized dental care with a superior filling based on nanotechnology. Were not saying 3M is a nanomaterials stock theyre actually a conglomerate but were simply saying that much of the progress being made with nanomaterials will be outsude of public eyes.

Then you have nanomaterials that people cant stop talking about, like graphene. In fact, there are quite a few publicly traded graphene stocks out there, any number of which should probably be avoided. Thats why we put together a A Guide to Investing in Graphene Stocks. Once youve read that or not lets move onto the really exciting stuff.

If we had to pick the single most exciting disruptive technology there is, that would have to be synthetic biology. The most efficient manufacturing known to man would have to be nature. Just think about the process of growing food using nothing but sunlight, water, and soil. Many futurist-minded people are thinking that soon well just grow everything we need using tools like gene editing. From what weve seen lately from companies like Ginkgo Bioworks, were off to a very good start.

Theres so much exciting stuff to talk about here that we put together a separate Guide to Investing in Synthetic Biology and A Guide to Investing in Gene Editing Stocks which looks at some areas of disruptive technology which we think will transform society more than even computing did.

The applications for nanotechnology in the healthcare sector are many. Its not progressed to biobots in your bloodstream yet, but its getting closer with many nano drug delivery mechanisms being commercialized.

Today, many companies are using nano drug delivery technologies. Some, like Bind Therapeutics, showed great potential, yet failed spectacularly. Nowadays, companies dont make a big deal about mentioning the use of nanotechnology, and many drug companies actively use nanoparticles to deliver drugs more efficiently. Here are some nano drug delivery companies weve looked at over the years, all of which happen to be publicly traded companies.

Other nano drug delivery companies like Cerulean Pharma didnt fare too well as they had to wind down their business after their lead drug a nanoparticle formulation that targeted cancer tumors failed in Phase 2 clinical trials. Ology Bioservices (previously known as Nanotherapeutics) was developing nanoparticles to make existing drugs more effective but has since pivoted into biomanufacturing.

From rejuvenating your skin to helping you quit smoking, nanotechnology has many uses in healthcare aside from just drug delivery. Venture capitalists continue to fund nanotechnology healthcare startups in all areas of healthcare. A recent example would be Nanox, a startup that is reinventing medical imaging with a new x-ray machine powered by a chip of nano-scale structures created using proprietary nanofabrication techniques. Another exciting startup to watch is Berkeley Lights and their nanofluidics platform that lets researchers quickly manipulate and measure cells at scale.

While the term nanotechnology has changed over the years, the promises it holds havent. Many companies are using nanotechnology, theyre just not shouting it from the rooftops. If you want to stay on top of what stocks to invest in based on the new definition of nanotechnology, we can help.

Sign up for our weekly newsletter. Well keep you up-to-date on everything nano along with many other disruptive technologies that ought to be on investors radar. No politics, no B.S., no corporate buzzword bingo.Click here to sign up for Nanalyze Weekly.

Read this article:
Investing in Nanotechnology Stocks and Companies - Nanalyze

C-Bond Systems Focuses on a New Transportation Disinfection Vertical: Golf Carts at Courses Throughout the U.S. – GlobeNewswire

HOUSTON, July 02, 2020 (GLOBE NEWSWIRE) -- C-Bond Systems (the Company or C-Bond) (OTC: CBNT), a nanotechnology solutions company, announced today that it is focusing on a new transportation disinfection vertical: golf carts at courses throughout the U.S. Through the launch of a targeted marketing campaign to golf courses throughout the U.S., the Company is marketing the use of MB-10 Tablets for the complete disinfection of golf carts between rounds.

MB-10 Tablets are an EPA-registered disinfectant approved for use against COVID-19, which is caused by SARS-CoV-2. MB-10 Tablets (EPA Reg No.70060-19-46269) are registered as a broad spectrum hospital disinfectant that is effective against a wide range of bacteria and viruses. A video showing the use of MB-10 Tablets to disinfect golf carts can be viewed by clicking here.

The Golf Course Superintendents Association of America suggests sanitizing golf carts after each round, and we believe MB-10 Tablets offer the fastest, most thorough and cost-effective way to do that to protect both players and golf course staff, said Scott R. Silverman, Chairman and Chief Executive Officer of C-Bond Systems.

Easy to apply using a commercially available sprayer, MB-10 effectively disinfects a golf carts exterior and interior in minutes. MB-10 provides fast-acting virus and bacteria protection that is safe for all vehicle surfaces without leaving a residue or odor. It is fast drying and safe for skin contact.

C-Bond has exclusive nationwide distribution rights to market MB-10 Tablets to all verticals within the transportation sector. This includes emergency vehicles, vehicle fleets, taxis, recreational vehicles, golf carts and more.

MB-10 Tablets kill viruses similar to SARS-CoV-2, and therefore according to the EPA Guidelines on Emerging Pathogens, can be used against SARS-CoV-2 on hard, nonporous surfaces. C-Bond sells MB-10 Tablets under an exclusive, nationwide distribution agreement with Quip Laboratories, Inc. for the domestic transportation sector.

About C-Bond C-Bond Systems, Inc. (OTC: CBNT) is a Houston-based advanced nanotechnology company and marketer of the patented C-Bond technology, developed in conjunction with Rice University and independently proven to significantly strengthen glass in key automotive and structural applications. The Companys Transportation Solutions Group sells C-Bond NanoShield, a liquid solution applied directly to automotive windshields, sold through distributors. The Companys Safety Solutions Group sells ballistic-resistant glass solutions and FN NANO Coating directly to private enterprises, schools, hospitals and government agencies. For more information, please visit our website:www.cbondsystems.com, Facebook: https://www.facebook.com/cbondsys/ and Twitter: https://twitter.com/CBond_Systems.

Forward-Looking StatementsStatements in this press release about our future expectations constitute "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, Section 21E of the Securities Exchange Act of 1934, and as that term is defined in the Private Litigation Reform Act of 1995. Such forward-looking statements involve risks and uncertainties and are subject to change at any time, and our actual results could differ materially from expected results. These risks and uncertainties include, without limitation, C-Bonds ability to raise capital; the Companys ability to successfully commercialize its products; the effect of the COVID-19 global pandemic on the Companys ability to operate; as well as other risks. Additional information about these and other factors may be described in the Companys filings with the Securities and Exchange Commission (SEC) including its Form 10-K filed on March 25, 2020, its Forms 10-Q filed on May 15, 2020, November 14, 2019, and August 12, 2019, and in future filings with the SEC. The Company undertakes no obligation to update or release any revisions to these forward-looking statements to reflect events or circumstances after the date of this statement or to reflect the occurrence of unanticipated events, except as required by law.

Link:
C-Bond Systems Focuses on a New Transportation Disinfection Vertical: Golf Carts at Courses Throughout the U.S. - GlobeNewswire

Case Western Reserve University-led team develops new approach to treat certain neurological diseases – Mirage News

A team led by Case Western Reserve University medical researchers has developed a potential treatment method for Pelizaeus-Merzbacher disease (PMD), a fatal neurological disorder that produces severe movement, motor and cognitive dysfunction in children. It results from genetic mutations that prevent the body from properly making myelin, the protective insulation around nerve cells.

Paul Tesar, professor of genetics and genome sciences, School of Medicine

Using mouse models, the researchers identified and validated a new treatment target-a toxic protein resulting from the genetic mutation. Next, they successfully used a family of drugs known as ASOs (antisense oligonucleotides) to target the ribonucleic acid (RNA) strands that created the abnormal protein to stop its production. This treatment reduced PMDs hallmark symptoms and extended lifespan, establishing the clinical potential of this approach.

By demonstrating effective delivery of the ASOs to myelin-producing cells in the nervous system, researchers raised the prospect for using this method to treat other myelin disorders that result from dysfunction within these cells, including multiple sclerosis (MS).

Their research was published online July 1 in the journal Nature.

The pre-clinical results were profound. PMD mouse models that typically die within a few weeks of birth were able to live a full lifespan after treatment, said Paul Tesar, principal investigator on the research, a professor in the Department of Genetics and Genome Sciences at the School of Medicine and the Dr. Donald and Ruth Weber Goodman Professor of Innovative Therapeutics. Our results open the door for the development of the first treatment for PMD as well as a new therapeutic approach for other myelin disorders.

Study co-authors include an interdisciplinary team of researchers from the medical school, Ionis Pharmaceuticals Inc., a Carlsbad, California-based pioneer developer of RNA-targeted therapies, and Cleveland Clinic. First author Matthew Elitt worked in Tesars lab as a Case Western Reserve medical and graduate student.

PMD is a rare, genetic condition involving the brain and spinal cord that primarily affects boys. Symptoms can appear in early infancy and begin with jerky eye movements and abnormal head movements. Over time, children develop severe muscle weakness and stiffness, cognitive dysfunction, difficulty walking and fail to reach developmental milestones such as speaking. The disease cuts short life-expectancy, and people with the most severe cases die in childhood.

The disease results from errors in a gene called proteolipid protein 1 (PLP1). Normally, this gene produces proteolipid protein (PLP) a major component of myelin, which wraps and insulates nerve fibers to allow proper transmission of electrical signals in the nervous system. But a faulty PLP1 gene produces toxic proteins that kill myelin producing cells and prevent myelin from developing and functioning properly-resulting in the severe neurological dysfunction in PMD patients.

PMD impacts a few thousand people around the world. So far, no therapy has lessened symptoms or extended lifespans.

For nearly a decade, Tesar and his team have worked to better understand and develop new therapies for myelin disorders. They have had a series of successes, and their myelin-regenerating drugs for MS are now in commercial development.

In the current laboratory work, the researchers found that suppressing mutant PLP1 and its toxic protein restored myelin-producing cells, produced functioning myelin, reduced disease symptoms and extended lifespans.

After validating that PLP1 was their therapeutic target, the researchers pursued pre-clinical treatment options. They knew mutations in the PLP1 gene produced faulty RNA strands that, in turn, created the toxic PLP protein.

Additional team members included Lilianne Barbar, Elizabeth Shick, Yuka Maeno-Hikichi, Mayur Madhavan, Kevin Allan, Baraa Nawash, Artur Gevorgyan, Stevephen Hung, Zachary Nevin, Hannah Olsen, Daniela Schlatzer, David LePage, Weihong Jiang and Ronald Conlon from Case Western Reserve University School of Medicine; Berit Powers, Hien Zhao, Adam Swayze and Frank Rigo from Ionis Pharmaceuticals; and Midori Hitomi from Cleveland Clinic.

This research was supported by grants from the National Institutes of Health, New York Stem Cell Foundation and European Leukodystrophy Association. Philanthropic support was provided by the Geller, Goodman, Fakhouri, Long, Matreyak, Peterson and Weidenthal families and the CWRU Research Institute for Childrens Health.

See original here:
Case Western Reserve University-led team develops new approach to treat certain neurological diseases - Mirage News

Gene C. Rousseau Recognized as a Professional of the Year for 2020 by Strathmore’s Who’s Who Worldwide – Benzinga

Snoqualmie, WA, July 03, 2020 --(PR.com)-- Gene C. Rousseau of Snoqualmie, Washington has been recognized as a Professional of the Year for 2020 by Strathmores Whos Who Worldwide Edition for his outstanding achievements and contributions for over 41 years in the machinery field.

About Gene C. RousseauGene C. Rousseau is the owner of TNG Machinery LLC, a longtime salesman for multiple woodworking companies covering Washington State and the Panhandle of Idaho who offers integrated metric solutions for wood, plastics and stone. TNG Machinery provides services to one man shops as well as large corporations. Their technology solutions can increase production and improve bottom lines. With over 41 years experience, Mr. Rousseau offers multiple values and liaises with cabinet companies. He provides metric solutions and assists with metric evaluations. Mr. Rousseau also serves as an intermediary for buying and selling used and new equipment.

Born on May 14, 1957 in Seattle, Washington, Gene attended Highline Community College and the University of Washington. Throughout his career, Mr. Rousseau has sold to the wood, plastic, stone and aerospace industries and has driven over 4.5 million miles. He was awarded Dealer of the Year in 2006 and 2007.

Gene married his beautiful wife Nicole in 1997 and they have two children, Tanner and Sydney. In his spare time, he enjoys fishing and coaching football.

For further information, contact https://www.tngmachinery.com.

About Strathmores Whos Who WorldwideStrathmores Whos Who Worldwide highlights the professional lives of individuals from every significant field or industry including business, medicine, law, education, art, government and entertainment. Strathmores Whos Who Worldwide is both an online and hard cover publication where we provide our members current and pertinent business information. It is also a biographical information source for thousands of researchers, journalists, librarians and executive search firms throughout the world. Our goal is to ensure that our members receive all of the networking, exposure and recognition capabilities to potentially increase their business.

Contact Information:Strathmore WorldwideSusan Perrault516-677-9696Contact via Emailwww.strathmoreworldwide.comSyndi Reibman

Read the full story here: https://www.pr.com/press-release/815106

Press Release Distributed by PR.com

Here is the original post:
Gene C. Rousseau Recognized as a Professional of the Year for 2020 by Strathmore's Who's Who Worldwide - Benzinga

I’ve been walking a work-life tightrope. It’s finally disintegrated and I’m ready to share my story – Women’s Agenda

For years Ive walked a tightrope with my professional life on one side and personal life on the other. Two very separate existences. Slowly, as Ive become more comfortable sharing my personal story the tightrope has become steadier. I have become more comfortable with the rope and learnt to stop looking down.

Today, after years of balancing (well at least attempting to), the tightrope has disintegrated, and Im still standing, now ready to share my story.

I have been dancing on the personal-work-life tightrope since 2012. The journey began eight years ago when my second daughter was three months old and I started consulting to AIA Australia to help launch Vitality into the Australian market.

Over the next three years, I juggled the darkest times of my personal life while effectively working in a start-up. I was in survival mode, emotionally for myself and literally for my children and I rarely mentioned a word of it to my colleagues.

My husband and I were dealing with our 2.5 year-old, Jaeli, who had developed uncontrolled seizures (in fact hundreds a day), extreme behaviours, autistic features, childhood insomnia, three-hour nightly and daily screaming fits, self-injurious behaviour and cognitive delays.

My second daughter, Dali, born 2 years after Jaeli, had hit all of her milestones at the age of one, beforewe saw it that first sign the subtle eye lid seizures. This time we knew how those subtle eyelid seizures would progress.

We were heartbroken.

In those early years, we were driven by the sense of urgency to get a diagnosis and fix our kids, acutely aware of the neurodevelopmental plasticity window closing further every day.

My survival technique was to compartmentalise.

I was in survival mode at home and work was my escape. An escape from the helplessness I felt watching our beautiful girls suffer, every attempt to help them only making them worse.

I didnt intentionally hide the situation from my colleagues, but I rarely mentioned it. I didnt want to burden others with my pain, I didnt want them to pity me and I definitely didnt want to be treated differently.

Unknowingly, I was protecting my illusion of control.

Our journey took a new direction and energy when we finally received a diagnosis for the girls in 2016. At that time they were four and six years old. We were one of the first in Australia to undergo whole genome sequencing, and after five long years we had a name for our enemy. It was a rare genetic epilepsy called Syngap. At the time, there were less than 100 diagnosed in the world, now, four years later, there are almost 600.

Knowledge is power and armed with a diagnosis, we became empowered to change our daughters destinies. We were buoyed learning that there has never been a better time for science, medical discoveries, precision medicine and gene therapy.

We connected with other families, with researchers and clinicians who gave us hope that precision medicine was a realistic concept for our kids.

Next, we established Syngap Research Fund Australia, co-founded Genetic Epilepsy Team Australia (GETA) and the Syngap Global Network. We advocated for whole genome sequencing, jumped into collating data on the condition which inspired the largest Syngap study, published in the neurology journal in 2019 on which I was a co-author. We lobbied government, leading to a $2m investment in genetic epilepsy research, which kickstarted our Syngap research project in 2018 at the Florey Institute for Neuroscience and Mental Health.

Weve learnt along the way that those who bear the burden of disease have an unrelenting passion like no other which accelerates scientific breakthroughs.

And, Ive slowly learnt, that the two worlds professional and personal that I had deliberately kept apart, could in fact benefit one another. I learnt the tightrope could in fact become a runway.

Professionally, I thrive in a team environment, partly because I own my shortcomings and naturally seek partnerships that combine complementary skillsets and genuinely subscribe to the shared value concept. I like to rely on others and I like to be relied on.

Personally, I am inspired by those I fight shoulder to shoulder with in battle from our Genetic Epilepsy Team Australia group, to the Syngap Global Network team, and my husband who is so driven and optimistic, grateful for that optimism especially when I am not.

Only recently have I realised the same theory of combining complementary skills applies to the two versions of myself the professional version and the rare disease mum version that each contribute to the same person.

Im surprised and grateful that the skills Ive obtained in each of these versions of myself are transferrable. That my persistence, optimism, passion, empathy, tolerance and resilience straddle both sides of that tightrope, ultimately bringing strength and balance to both.

Through this journey, Ive also learnt the power of gratitude. I am grateful for my family, friends, community and personal network that have loved me in my darkest times. And, I am indebted to AIA Australia, and particularly Damien Mu, who have supported me professionally, and who chose to keep my tightrope taut when I felt the need to keep my two roles as employee and rare disease mum balanced, but apart.

Today, after eight years trying to balance the tightrope, I feel empowered by that runway on which I can make a difference in both my professional and personal roles.

This is an edited version of a post that Danielle first published on LinkedIn. Its shared here with permission.

For more information on Syngap Research Australia, click here. Or check them out on Facebook or Twitter.

You can find more information on GETA: Genetic Epilepsy Team Australia here, or on Facebook or Twitter

Go here to see the original:
I've been walking a work-life tightrope. It's finally disintegrated and I'm ready to share my story - Women's Agenda

Learning to Live Sustainably on the Red Planet: Habitat Mars – Universe Today

Theres quite a bit of buzz these days about how humanity could become a multiplanetary species. This is understandable considering that space agencies and aerospace companies from around the world are planning on conducting missions to Low Earth Orbit (LEO), the Moon, and Mars in the coming years, not to mention establishing a permanent human presence there and beyond.

To do this, humanity needs to develop the necessary strategies for sustainable living in hostile environments and enclosed spaces. To prepare humans for this kind of experience, groups like Habitat Marte (Mars Habitat) and others are dedicated to conducting simulated missions in analog environments. The lessons learned will not only prepare people to live and work in space but foster ideas for sustainable living here on Earth.

Habitat Marte was founded in 2017 by Julio Francisco Dantas de Rezende, the professor of sustainability in the Department of Product Engineering at the Federal University of Rio Grande do Norte (UFRN) and the Director of Innovation with the State Foundation to Research Support (FAPERN). He is also the Coordinator of Habitat Marte and Mars Society Brazil.

Prof. Rezende was inspired to bring the Mars Society to Brazil after attending their 2016 convention in Washington DC, where famed scientists and founder Robert Zubrin spoke of their mission. These include conducting simulated missions at their analog environments located in Utah (the Desert Mars Research Station) and Nunavut, Canada (the Flashline Mars Arctic Research Station).

Inspired by this work, Prof. Rezende returned to Brazil and dedicated his own resources to launch similar initiatives. The result was the Mars Society Brazil and the creation of its Habitat Marte training environment. As a location, they chose the semi-arid region of Caiara do Rio do Vento about 100 km (62 mi) west of Natal a rugged region that receives rainfall only a few times a year, making it a good approximation to Mars.

At present, this training environment remains the only Mars analog station operating in the southern hemisphere and, like its counterparts in other countries, is dedicated to developing the skills and technologies necessary to live sustainably on Mars and other planets. As Prof Julio Rezende explained to Universe Today via email:

[W]e are interested in designing systems that collaborate to have a self-sustainable/circular system in which the energy itself is generated, the waste generated is recycled and the food itself is produced. At Habitat Marte we are committed to the development of social technologies such as greenhouses, solar oven, cisterns, aquaponics, water filters, and greenhouses. Our challenge is to develop technologies that are applied both to space and in arid and semi-arid regions, or other regions threatened by water scarcity and droughts.

Between December of 2017 and 2020, Habitat Marte has conducted 42 missions with more than 150 participants, totaling almost 1300 hours (98 days) of mission time. As Prof. Rezende indicated, these activities have generated large volumes of data that has resulted in a variety of scientific studies and publications. For each mission, applicants spend time in the simulated habitat and conducting the following activities:

In terms of food, the crews grow all the fruits and vegetables they will need, which has included eggplant, lettuce, bananas, tomatoes, peppers, and sweet potatoes in the past apologies to Mark Watney for the lack of redskins, russets, purple, and other potatoes! For the sake of protein, the crews also farmed tilapia fish, and grew basil and cilantro for flavor and added nutrition.

Theyve even cultivated trees for the sake of reforestation at home (and possibly terraforming on Mars!) When not working inside, the teams would conduct extra-vehicular activity (EVA) walks outdoors while wearing spacesuits. In one instance, a team conducted an EVA to Pico do Cabugi (Cabugi Peak), an extinct volcano located about 40 km (25 mi) from the training grounds that stands 590 meters (1935 ft) in height (shown below).

While there, the team took rock samples which they will examine with the help of the geology labs in UFRN. Prof. Rezende and his colleagues also hope to use finely ground rock samples to develop a Mars soil simulant, which they will use to test the viability of growing Earth crops in Martian soil. For this research, they will be collaborating with Prof. Wieger Wamelink of the Wageningen University & Research Center in the Netherlands.

For loyal readers of Universe Today (or fans of MarsOne), Dr. Wamelink ought to be a familiar name. A few years ago, Dr. Wamelink and colleagues from Wageningen University conducted a series of agricultural studies in conjunction with MarsOne. This involved growing different types of crops in Lunar and Martian soil simulants to see which would germinate, grow, and be safe for consumption.

Between 2013 and 2015, they confirmed that a total of ten crops (including rye, radishes, garden cress, peas, green beans, tomatoes and potatoes) could all grow in Martian soil. They further found that seeds produced from these crops were able to germinate as well, thus ensuring successive harvests, and that the plants did not retain harmful levels of heavy metals (which are common in lunar and Martian soil).

Due to the coronavirus epidemic, these missions have been temporarily suspended but will resume soon. The last mission took place on March 14th, 2020, In the meantime, Prof. Rezende and his colleagues have carried on with virtual simulations, which is what the last 6 missions have been. As he described them:

In virtual missions, participants are invited to participate in remote activities related to the Habitat Marte protocols and research themes that associate space and sustainability, observing how Habitat Marte can contribute to solutions related to isolation during the coronavirus period. We realized that the actions of Habitat Marte may present guidelines for this challenging moment.

This is a common theme among researchers, scientists, and advocates that are dedicated to finding solutions to the problem of living in space. For example, Vera Mulyani (Vera Mars) recently stated how this years Mars City Design competition which is focused on Urban Farming has drawn inspiration from the pandemic and the need for social isolation.

In this time of crisis, envisioning how to live abundantly on another planet seems to be a far-off predicament, she said. However, this critical time can also offer a new perspective, a change that in the long term, is necessary for the sake of our existence and evolution as human beings. This initiative can also lead to technological discoveries and innovations. Pursuing a vision of tomorrow may save today before it is too late!

Another common element is the way research into living sustainability on other planets can have positive consequences here on Earth. In the past, efforts to send astronauts to space and the Moon (the Apollo Program) resulted in countless applications here on Earth, ranging from respirators, heart monitors, and microwave ovens to GPS, satellite communications, microchips, and solar panels.

It is therefore easy to see how Project Artemis, missions to Mars, and other plans to go interplanetary will help address problems here at home. With the global population expected to reach 10 billion by mid-century, and the way climate change will disrupt the natural systems we depend upon to live, knowing how to do more with less resources (and produce less waste) is vital to our survival.

Prof. Rezende himself expressed how this connection between Earth and exploring/living off-world is at the heart of Habitat Martes mission:

We are interested in creating a new generation of people interested in science and technology, seeing knowledge as a tool to collaborate for sustainable development. We believe that the experience at Habitat Mars is motivating for its participants to empower themselves and expand their vision, based on a spatial experience, which can change the world, collaborating for a more prosperous world.

[We are] also committed to presenting solutions for semiarid regions in Brazil. Mainly based in social technologies. Some also possibly adapted to space habitats. We have two pillars: space and arid/ semiarid regions. Because I consider that areas affected by climate change will become more. Our initiatives are connected with the 17 Sustainable Development Goals.

These goals were set by the UN in 2015 to act as a blueprint to achieve a better and more sustainable future for all. In addition to the elimination of all forms of inequality, the SDGs call for the elimination of poverty and hunger, as well as action on climate change, the provision of clean water and sanitation, and the development of sustainable cities and communities by 2030.

Key to accomplishing these goals is the development of technologies and methods that allow human beings to use local resources more wisely and sustainability and minimize their impact on the local environment. In this respect, the work being conducted by Habitat Marte, The Mars Society, HI-SEAS, and groups like Mars City Design and Stellar Amenities will have implications that go far beyond space!

To learn more about Habitat Marte, check out their website and their page at the United Nations Office of Outer Space Affairs (UNOOSA). You can also find testimonials recorded by people who have participated in their missions here.

Further Reading: Habitat Marte

Like Loading...

View post:

Learning to Live Sustainably on the Red Planet: Habitat Mars - Universe Today

Litecoin price prediction 2020: can it become the best …

Only 10 years ago, no one knew what a blockchain was. Today, there are hundreds of well-established and emerging cryptocurrencies using blockchain technology to supplant traditional fiat money and change the way we live.

Litecoin (LTC) has drawn a lot of investor interest after hitting the headlines in December 2017. Then, the cryptocurrency reached its record high of $375, an 8,200 per cent increase year-on-year, hitting a total LTC market cap of $19.5 billion.

However, following the latest crypto market news where prices have fallen across the board, many now wonder: will Litecoin go up once again? Can it fully recover and set some new records after the bumpy ride of the second half of 2019?

While this year is about to come to an end, closing the first decade of cryptos existence, analysts are split in their Litecoin price predictions. Some experts say that its current all-time high could be just a drop in the bucket and predict the coin to hit an overwhelming $595 by 2030. Others take a bearish stance, believing that another crypto winter is yet to come, with Litecoin future price dropping as low as $1.5 by the end of 2024.

So, if you are wondering, should I invest in Litecoin or not? we have you covered. In this article, we try to find the truth by taking a closer look at what factors influence this cryptocurrency, reviewing its recent performance, analysing the latest developments and checking out the Litecoin price prediction for 2020 and beyond.

Before we delve deep into the Litecoin price predictions, lets do a quick review on what LTC is.

On October 7, 2011, Litecoin (LTC) was created by Charlie Lee, an ex-Google employee and former Engineering Director at Coinbase. Designed as a peer-to-peer network with the same-name native cryptocurrency, it was launched to complement Bitcoin by solving issues like concentrated mining pools and transaction timings, as well as to make the crypto world more accessible.

Truth be told, these two do share a lot in common. However, there are still some substantial advantages that Litecoin boasts of. These include, among others, improved capacity, faster block generation and higher supply limits.

On the other hand, as Litecoins purpose initially was to be silver to Bitcoin gold, some sceptics call into question whether it will ever be able to become anything more than its main rival. While Litecoin technically has a superior algorithm, it may be rather irrelevant since Bitcoins popularity has cemented it as the gold standard for old and new crypto traders. Moreover, the next-gen altcoins are emerging almost daily, taking the industry's competition to a whole other level.

After its launch, Litecoin was fast to get the attention of the small yet growing crypto community of the time. Nonetheless, its value had remained rather low around $3 for quite a long time. It was only in November 2013 when the market finally saw the first significant price movements. On November 28, LTC value almost doubled within one day and reached the price of $50 per coin.

However, such a substantial jump was short-lived. In April 2014, Litecoin dropped to $10 and further to a little over $1 in February 2015. The crypto was then traded in the range of $1-$4 for the next two years.

In March 2017, Litecoin announced the launch date of their Segregated Witness (SegWit) protocol upgrade. The statement had a positive impact on the coins rate, with its value rising to $16. In May, the protocol changes were finally implemented, making LTC the first of the top five cryptocurrencies to adopt SegWit and pushing its price to $30.

Meanwhile, the dev team implemented the Lightning Network, attracting a lot of attention from the crypto enthusiasts. By September, LTC reached $70. With the whole market being bullish, sending Bitcoin and altcoins to set new price records, Litecoin hit its all-time high of $375 in mid-December.

For the most part of 2018, Litecoin was in a bearish trend. Despite its well-established position in the industry, the coin was affected by the overall descending dynamic of the market. The downward Litecoin trend only changed a couple of times: in February and April. All-in-all, the coins price decreased almost five times over the course of the year.

At the end of 2018, things started getting better, and Litecoin managed to stabilise, finally gaining an upside momentum.

At the beginning of 2019, Litecoin continued its price growth. During the first half of the year, LTC price increased four times from $31.02 to $138.4. The reason for such a significant price hike was the upcoming Litecoin halving, which happened on August 5.

However, the event was followed by the much-expected correction, with the price of Litecoin dropping as low as $68 by mid-September. Throughout the rest of the year, the coin remained in the downward trend. At the time of writing, on December 20, LTC traded at $40.

Back in the days, Litecoin was at the forefront of modern and relevant technologies. Its early implementation of SegWit protocol and Atomic swaps has revolutionised the sphere of the cryptocurrency payments.

However, Litecoin has been recently struggling with many difficulties. Now that Bitcoin also introduced SegWit, the altcoin lacks one of its crucial competitive advantages.

Joe DiPasquale, CEO of cryptocurrency hedge fund manager BitBull Capital, said: Litecoin's price action has historically followed Bitcoin's, but currently it is facing negativity on multiple fronts. In the absence of new capital flow, transaction volumes have remained tame and the August halving has failed to push the price higher.

He also added: In fact, miners have begun to abandon the network after the reward-reduction, which is why the hashrate is falling and concerns are being raised about the network's security.

Marouane Garcon, managing director of crypto-to-crypto derivatives platform Amulet, also weighed in, saying that Litecoin's recent price decline has more to do with the concerns about development and how they are going to be funded going forward.

Earlier this year, Charlie Lee reportedly told Franklyn Richards, director of Litecoin Foundation, that no one is interested in working on Litecoin protocol development work. After this information was disclosed, peoples perspective of Litecoin changed, continued Garcon. Litecoin has not been the same since that announcement, he added.

It threw everyone into a panic. If no one is willing to work on Litecoin and develop it then why should anyone invest in it?

Based on the latest study conducted by Sylvain Saurel, the potential of Litecoin is very limited. He explained that the coin peaked in 2017 as it was riding on Bitcoins wave of success, taking advantage of the increasing number of interested investors. Although Litecoin remains in the top 10 cryptocurrencies by market cap, this number is still too far from its record high of $19 billion.

Saurel claims: Litecoin will certainly remain in the top 10 of cryptocurrencies for some time to come, but its future is clearly not alongside Bitcoin that could revolutionise the monetary and financial system in the future.

Historic oil price dropDon't miss your trading opportunities

Litecoin has reported a decrease in its hashrate since mid-2019, reaching its lowest levels since 2018.

At the time of writing, its hashrate was 147.4 TH/s. If the fall is prolonged, it could negatively affect the future performance of Litecoin.

However, it is important to note that the network is now working on some major changes. According to the latest news, the Litecoin Foundation is currently cooperating with Steve Burkett, a developer of the Grin project, to implement MimbleWible in the Litecoin protocol. Once realised, Litecoin could move away from Bitcoin, creating a unique selling point. On the other hand, innovation will reduce fungibility, possibly making Litecoin susceptible to being blocked from important exchanges.

All in all, Litecoin has a great advantage to make improvements to itself much faster than Bitcoin does. However, with the rapid development of new crypto projects that have base codes that are already more fit for micro-transactions and scaling, has Litecoin missed its chance to stay on top?

It is no secret that the crypto market moves at a rapid pace, making it rather difficult to predict its future. We have made our own investigation to compile a list of the latest Litecoin forecasts from various sources.

Based on technical analysis, TradingBeasts.com, a popular crypto forecast website, predicted that by the end of next year, LTC price will be around $46.23; and only a bit higher in 2021 up to $67.23. By December 2022, Litecoin is expected to grow to an average of $82.68.

A more optimistic LTC price forecast is provided by Cryptoground.com. Based on an internal deep learning algorithm, it states that LTC will reach $88.30 in one year, rising almost 109.81 per cent. It is expected that the growth will continue, with the coin trading at $347.8 by the end of 2024.

According to the information provided by CoinFan.com, another famous online forecasting service, Litecoin future predictions look rather promising, with LTC prognosed to end 2020 at $276.4. Their long-term forecast suggests the coin will hit $506.8 by May 2025.

George Tung, a cryptocurrency analyst, has the most positive Litecoin projections, saying its price might rise as high as $1,500 towards the end of 2020.

Looking forward, DigitalCoinPrice.com states that Litecoin will have moderate price growth. The positive trend is expected to prevail, with the coin trading at $72 in December 2026.

Regarding the Litecoin price prediction 2030, the coin is expected to end the following decade at $251.44, according to CoinPriceForecast.com.

However, not everyone has taken a bullish stance. Walletinvestor.com, known for their pragmatic forecasts, refers to LTC as a bad, high-risk one-year investment option. According to their Litecoin predictions, the coin is expected to lose in value significantly, with its price falling to $4.5 by August 2020. However, it is expected to recover by fall and end next year at $36.8.

In five years, Wallet Investor estimates the coin to drop as low as $0.77 by the end of 2024.

The crypto market has experienced several ups and downs over this year. While all the talks revolve around digital money, there are still many questions to answer.

Will Litecoin rise and live up to the expectations of analysts? As you can understand, there is no definite answer to this question. It is very difficult to predict what the price of Litecoin could be in a few hours; and even harder to give long-term estimates. However, according to the forecasts mentioned above, LTC is mainly prognosed to move in a positive direction.

Is Litecoin a good investment for the long term? Well, many crypto enthusiasts believe that the project has the technological strengths that could help it to become even more popular in the crypto world.

When choosing what cryptocurrency to invest in, it is always crucial to consider the latest technical analysis, expert opinion and market trends. For that, we recommend you do as much research as possible.

If you think you are not ready to make long-term investment commitments, but still want to try to profit from the market volatility, you can do so through contracts for difference (CFD).

You can learn more about CFD trading with free online courses and find out how to trade Litecoin CFDs by reading our comprehensive guide. Always stay on top of the Litecoin latest news with Capital.com.

So, what do you think about the future of this digital coin? Will Litecoin go down or soar to hit new record highs? Do you have an LTC price prediction of your own?

Follow our live LTC/USD chart and make your own bets!

Ready to get started?

Download Capital.com

Original post:

Litecoin price prediction 2020: can it become the best ...

Cryptocurrencies Price Prediction: Bitcoin, Ethereum & Litecoin American Wrap 7/1/2020 – Benzinga

Bitcoin Technical Analysis: BTC/USD Eyes$9,300 After 1% Surge

Bitcoin has been fairly weak for the past month, especially after losing the daily uptrend. Bulls are now trying to climb and close above the daily 12-EMA, established at around $9,250. This is the first resistance level buyers need to beat, the next is located at $9,322, the daily 26-EMA.

We know that Ethereum outperformed Bitcoin during May by quite a lot. The digital asset was one of the few top coins to see a significant bull rally while everyone else was sleeping. ETH/USD managed to peak at $253.47 before entering a consolidation period. While Ethereum has been trading sideways for the past few weeks, the pair against Bitcoin has remained fairly strong.

Litecoin is currently under a lot of selling pressure, the small bullish breakout from Bitcoin is helping Litecoin but its certainly not enough. The daily downtrend is still here and bulls will need a lot of strength to reverse the trend.

Photo by Thought Catalog from Pexels.

2020 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

Originally posted here:

Cryptocurrencies Price Prediction: Bitcoin, Ethereum & Litecoin American Wrap 7/1/2020 - Benzinga

Litecoin, Stellars Lumen, and Trons TRX Daily Analysis July 2nd, 2020 – Yahoo Finance

Litecoin

Litecoin rose by 1.55% on Wednesday. Partially reversing a 1.70% slide from Tuesday, Litecoin ended the day at $41.80.

A bearish start to the day saw Litecoin fall to an early morning afternoon intraday low $40.96 before making a move.

Steering clear of the first major support level at $40.58, Litecoin rallied to a late afternoon intraday high $42.02.

Litecoin broke through the first major resistance level at $41.91 before falling back to sub-$41.60 levels.

Finding late support, Litecoin revisited $42 levels before easing back. The first major resistance level capped the upside on the day.

At the time of writing, Litecoin was down by 0.26% to $41.69. A mixed start to the day saw Litecoin rise to an early morning high $41.91 before falling to a low $41.66.

Litecoin left the major support and resistance levels untested early in the day.

Litecoin would need to avoid a fall through the $41.60 pivot to support a run at the first major resistance level at $42.23.

Support from the broader market would be needed, however, for Litecoin to break out from Wednesdays high $42.02.

Barring another crypto rally, the first major resistance level and Wednesdays high $42.02 would likely cap any upside.

Failure to avoid a fall through the $41.60 pivot could see Litecoin struggle on the day.

A fall back through to sub-$41.50 levels would bring the first major support level at $41.17 into play.

Barring an extended crypto sell-off, Litecoin should steer clear of sub-$40 levels. The second major support level at $40.53 should limit any downside.

Major Support Level: $41.17

Major Resistance Level: $42.23

23.6% FIB Retracement Level: $62

38.2% FIB Retracement Level: $78

62% FIB Retracement Level: $104

Stellars Lumen rose by 1.96% on Wednesday. Following on from a 2.85% rally on Tuesday, Stellars Lumen ended the day at $0.068009.

A bearish start to the day saw Stellars Lumen fall to an early morning intraday low $0.066166.

Steering clear of the first major support level at $0.06518, Stellars Lumen rallied to a late afternoon intraday high $0.069447.

Stellars Lumen broke through the first major resistance level at $0.06816 and the second major resistance level at $0.06816.

A late pullback saw Stellars Lumen fall back to sub-$0.068 levels before recovering to $0.068 levels. The first major resistance level at $0.06816 capped the upside late in the day.

At the time of writing, Stellars Lumen was up by 2.50% to $0.069707. A bullish start to the day saw Stellars Lumen rally from an early morning low $0.069377 to a high $0.069707.

Stellars Lumen left the major support and resistance levels untested early on.

Story continues

Stellars Lumen would need to avoid a fall through the $0.06790 pivot to support a run at the first major resistance level at $0.06958.

Support from the broader market would be needed, however, for Stellars Lumen to break out from the morning high $0.069707.

Barring another broad-based crypto rally, the first major resistance level would likely limit any upside.

A fall through the $0.06790 pivot could see Stellars Lumen struggle throughout the day.

A pullback through to sub-$0.067 levels would bring the first major support level at $0.06630 into play.

Barring an extended crypto sell-off, however, Stellars Lumen should steer clear of the second major support level at $0.06459.

Major Support Level: $0.06630

Major Resistance Level: $0.06958

23.6% FIB Retracement Level: $0.1051

38% FIB Retracement Level: $0.14336518

62% FIB Retracement Level: $0.2050

Trons TRX rallied by 3% on Wednesday. Following on from a 1.17% gain on Tuesday, Trons TRX ended the day at $0.016845.

A bearish start to the day saw Trons TRX fall to an early morning intraday low $0.016241 before making a move.

Steering clear of the first major support level at $0.01620, Trons TRX rallied to a late afternoon intraday high $0.017036.

Trons TRX broke through the first major resistance level at $0.01662 and the second major resistance level at $0.01684.

A late pullback saw Trons TRX fall back to sub-$0.01680 levels before revisiting $0.01695 levels.

The second major resistance level at $0.01684 pinned Trons TRX back late in the day.

At the time of writing, Trons TRX was up by 1.32% to $0.017068. A bullish start to the day saw Trons TRX rise from an early morning low 0.016901 to a high $0.017136.

Trons TRX left the major support and resistance levels untested early on.

Trons TRX would need to avoid a fall through the $0.01670 pivot to support a run at the first major resistance level at $0.01717.

Support from the broader market would be needed, however, for Trons TRX to break out from the morning high $0.017136.

Barring another broad-based crypto rally, the first major resistance level would likely cap any upside.

Failure to avoid a fall through the $0.01670 pivot would bring the first major support level at $0.01638 into play.

Barring another extended crypto sell-off, Trons TRX should steer clear of sub-$0.016 levels. The second major support level sits at $0.01591.

Major Support Level: $0.01638

Major Resistance Level: $0.01717

23.6% FIB Retracement Level: $0.0322

38.2% FIB Retracement Level: $0.0452

62% FIB Retracement Level: $0.0663

Please let us know what you think in the comments below

Thanks, Bob

This article was originally posted on FX Empire

Continued here:

Litecoin, Stellars Lumen, and Trons TRX Daily Analysis July 2nd, 2020 - Yahoo Finance

Litecoin, Stellars Lumen, and Trons TRX Daily Analysis June 30th, 2020 – Yahoo Finance

Litecoin

Litecoin rose by 1.28% on Monday. Following on from a 0.71% gain on Sunday, Litecoin ended the day at $41.87.

It was a mixed start to the day. Litecoin rose to an early morning high $41.53 before sliding to a late morning intraday low $40.57.

Coming within range of the first major support level at $40.47, Litecoin rallied to a late intraday high $42.24.

Litecoin broke through the first major resistance level at $42.11 before easing back to sub-$42 levels.

At the time of writing, Litecoin was down by 0.05% to $41.85. A mixed start to the day saw Litecoin rise to an early morning high $41.99 before falling to a low $41.78.

Litecoin left the major support and resistance levels untested early in the day.

Litecoin would need to avoid a fall through the $41.56 pivot to support a run at the first major resistance level at $42.55.

Support from the broader market would be needed, however, for Litecoin to break out from Mondays high $42.24.

Barring another crypto rally, the first major resistance level would likely cap any upside.

Failure to avoid a fall through the $41.56 pivot could see Litecoin struggle on the day.

A fall through to sub-$41 levels would bring the first major support level at $40.88 into play.

Barring an extended crypto sell-off, Litecoin should steer clear of the second major support level at $39.89.

Major Support Level: $40.88

Major Resistance Level: $42.55

23.6% FIB Retracement Level: $62

38.2% FIB Retracement Level: $78

62% FIB Retracement Level: $104

Stellars Lumen rose by 0.69% on Monday. Following on from a 2.39% rally on Sunday, Stellars Lumen ended the day at $0.06478.

Tracking the broader market, Stellars Lumen rose to an early morning high $0.06494 before hitting reverse.

Falling short of the major resistance levels, Stellars Lumen fell to a late morning intraday low $0.06300.

Steering clear of the first major support level at $0.06226, Stellars Lumen rallied to a late intraday high $0.065420.

Stellars Lumen came within range of the first major resistance level at $0.06544 before easing back to sub-$0.065 levels.

At the time of writing, Stellars Lumen was down by 0.22% to $0.064938. A mixed start to the day saw Stellars Lumen rise to an early morning high $0.065175 before sliding to a low $0.064882.

Stellars Lumen left the major support and resistance levels untested early on.

Story continues

Stellars Lumen would need to avoid a fall through the $0.06440 pivot to support a run at the first major resistance level at $0.06580.

Support from the broader market would be needed, however, for Stellars Lumen to break out from Mondays high $0.065420.

Barring another broad-based crypto rally, the first major resistance level and Mondays high would likely limit any upside.

Failure to avoid a fall through the $0.06440 pivot could see Stellars Lumen struggle throughout the day.

A fall back through to sub-$0.064 levels would bring the first major support level at $0.06338 into play.

Barring another extended crypto sell-off, however, Stellars Lumen should steer clear of sub-$0.060 levels. The second major support level at $0.06198 should limit any downside on the day.

Major Support Level: $0.06338

Major Resistance Level: $0.06580

23.6% FIB Retracement Level: $0.1051

38% FIB Retracement Level: $0.1433

62% FIB Retracement Level: $0.2050

Trons TRX rallied by 2.52% on Monday. Following on from a 1.94% gain on Sunday, Trons TRX ended the day at $0.01619.

Bullish throughout the day, Trons TRX rallied from an early morning intraday low $0.015786 to a late intraday high $0.016380.

Steering clear of the major support levels, Trons TRX broke through the first major resistance level at $0.01602.

Coming up against the second major resistance level at $0.01631, Trons TRX eased back to sub-$0.01620 levels.

At the time of writing, Trons TRX was up by 0.19% to $0.016220. A relatively bullish start to the day saw Trons TRX rise from an end of Sunday $0.01619 to an early high $0.01622

Trons TRX left the major support and resistance levels untested early on.

Trons TRX would need to avoid a fall through the $0.01612 pivot to support a run at the first major resistance level at $0.01645.

Support from the broader market would be needed, however, for Trons TRX to break out from Mondays high $0.01638.

Barring another broad-based crypto rally, the first major resistance level and Mondays high would likely cap any upside.

Failure to avoid a fall through the $0.01612 pivot would bring the first major support level at $0.01586 into play.

Barring another extended crypto sell-off, Trons TRX should steer clear of sub-$0.015 levels. The second major support level at $0.01552 should limit any downside.

Major Support Level: $0.01586

Major Resistance Level: $0.01645

23.6% FIB Retracement Level: $0.0322

38.2% FIB Retracement Level: $0.0452

62% FIB Retracement Level: $0.0663

Please let us know what you think in the comments below

Thanks, Bob

This article was originally posted on FX Empire

Read the rest here:

Litecoin, Stellars Lumen, and Trons TRX Daily Analysis June 30th, 2020 - Yahoo Finance

Litecoin (LTC) Up $0.24 On 4 Hour Chart, Started Today Up 1.48%; in a Downtrend Over Past 14 Days – CFDTrading

Litecoin 4 Hour Price Update

Updated July 02, 2020 01:35 AM GMT (09:35 PM EST)

Litecoin entered the current 4 hour candle at $41.88, up 0.58% ($0.24) from the last 4 hour candle. Litecoin outperformed all 5 assets in the Top Cryptos asset class since the last 4 hour candle.

Litecoin entered today at $41.8, up 1.48% ($0.61) from yesterday. The price move occurred on volume that was up 8.26% from the day prior, but down 40.47% from the same day the week before. Out of the 5 instruments in the Top Cryptos asset class, Litecoin ended up ranking 2nd for the day in terms of price change relative to yesterday. Below is a daily price chart of Litecoin.

Notably, Litecoin is now close to its 20 and 100 day averages, located at 43.11 and 43.63 respectively, and thus may be at a key juncture along those timeframes. Trend traders will want to observe that the strongest trend appears on the 30 day horizon; over that time period, price has been moving down. Price action traders in particular will want to note that the 90 day period appears to show price forming a base; this could indicate that a support/resistance level is developing. For another vantage point, consider that Litecoins price has gone down 17 of the previous 30 trading days.

For laughs, fights, or genuinely useful information, lets see what the most popular tweets pertaining to Litecoin for the past day were:

Thanks for the suggestions guys, it seems @changeangel_io is a top draw, how did I not know about this exchange before? Very easy to use, great exchange rate. My exchange is now done and my Digibyte out weigh my litecoin now. Thank you!

@CurrencyDesign @btccentermiami @CointelegraphZN @CoinFestUK @CoinJournal @xbtnews101 @MrSpinnyG @litecoin_bull Pay credit where its due the notes are definitely a good vehicle to spread the #btc message.Maybe backs could explain concepts like Bitcoins sound money fundamentals so people see that although volatile & used for speculation, its also a superior long term SoV to fiat.

@shreena74052483 @litecoin_bull @ROYALMRBADNEWS I found , that it actually did my brain a rest just sitting.. inner peace.. no guilt to just sit as you are being forced too.. when have we ever been forced to chill out.. use it .

See the article here:

Litecoin (LTC) Up $0.24 On 4 Hour Chart, Started Today Up 1.48%; in a Downtrend Over Past 14 Days - CFDTrading

Litecoin (LTC) Up $0.24 in Last 4 Hours, Underperforms All Top Cryptos to Start the Day; 2 Day Up Streak Ended – CFDTrading

Litecoin 4 Hour Price Update

Updated July 01, 2020 11:19 PM GMT (07:19 PM EST)

The back and forth price flow continues for Litecoin, which started the current 4 hour candle off at 41.88 US dollars, up 0.58% ($0.24) from the previous 4 hours. On a relative basis, the previous 4 hours were pretty good: Litecoin bested all 5 of the assets in the Top Cryptos class

41.19 (USD) was the opening price of the day for Litecoin, resulting in the day prior being one in which price moved down 1.65% ($0.69) from the day prior. The price move occurred on volume that was down 50.73% from the day prior, but up 15.94% from the same day the week before. Those trading within the Top Cryptos asset class should know that Litecoin was the worst performer in the class during the day prior. The daily price chart of Litecoin below illustrates.

The first thing we should note is that Litecoin is now close to its 20 day moving averages, which may act as price barrier for the asset. The clearest trend exists on the 30 day timeframe, which shows price moving down over that time. Or to view things another way, note that out of the past 30 days Litecoins price has gone down 17 them.

Over on Twitter, here were the top tweets about Litecoin:

On chain volume for #Litecoin over the past 24 hours was 2,165,307 #LTC That equals ~90,200 LTC per hour in trxs, or $3,726,200 worth of LTC sent and received per hour.

Flip your LTC for HEX, now that LTC it still has value, HEX the best defi project of 2020 for years LTC is not moving get more out of HEX staking, benefits and bigpayday LTC does not have this @litecoin

@btccentermiami @CurrencyDesign @CointelegraphZN @CoinFestUK @CoinJournal @xbtnews101 @MrSpinnyG @litecoin_bull Love it. Tom does great work. Best in the industry producing this format, no doubt. In terms of impacting adoption assuming pre-coiners will interact with the notes, itd be ideal to have more educational copy on them. However not all crypto artists double as #propagandists

Visit link:

Litecoin (LTC) Up $0.24 in Last 4 Hours, Underperforms All Top Cryptos to Start the Day; 2 Day Up Streak Ended - CFDTrading